Elizabeth A. Lopes
Av. Prof. Gama Pinto
Lisbon, 1649003, Portugal
Lisbon, 1649003, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Drugging p53 mutants: Recent advances using small-molecule modulation strategies.
Journal: European journal of medicinal chemistry
Published: April 02, 2026
Hybrid molecules of protoflavones and spirooxindole derivatives with selective cytotoxicity against triple-negative breast cancer cells.
Journal: RSC medicinal chemistry
Published: June 05, 2023
Antimalarial drugs: what's new in the patents?
Journal: Expert opinion on therapeutic patents
Published: April 15, 2023
Discovery of MDM2-p53 and MDM4-p53 protein-protein interactions small molecule dual inhibitors.
Journal: European journal of medicinal chemistry
Published: June 10, 2022
Discovery of spirooxadiazoline oxindoles with dual-stage antimalarial activity.
Journal: European journal of medicinal chemistry
Published: November 17, 2021
Mutant p53 reactivator SLMP53-2 hinders ultraviolet B radiation-induced skin carcinogenesis.
Journal: Pharmacological research
Published: September 30, 2021
Potency and Selectivity Optimization of Tryptophanol-Derived Oxazoloisoindolinones: Novel p53 Activators in Human Colorectal Cancer.
Journal: ChemMedChem
Published: July 15, 2020
Small Molecules Targeting Mutant P53: A Promising Approach for Cancer Treatment.
Journal: Current medicinal chemistry
Published: June 12, 2018
An Update on MDMX and Dual MDM2/X Inhibitors.
Journal: Current topics in medicinal chemistry
Published: November 20, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026